HomeComparePTHL vs EQR

PTHL vs EQR: Dividend Comparison 2026

PTHL yields 710.48% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTHL wins by $1027533.81M in total portfolio value
10 years
PTHL
PTHL
● Live price
710.48%
Share price
$0.28
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1027533.85M
Annual income
$804,724,505,670.28
Full PTHL calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — PTHL vs EQR

📍 PTHL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTHLEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTHL + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTHL pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTHL
Annual income on $10K today (after 15% tax)
$60,390.76/yr
After 10yr DRIP, annual income (after tax)
$684,015,829,819.74/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, PTHL beats the other by $684,015,825,165.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTHL + EQR for your $10,000?

PTHL: 50%EQR: 50%
100% EQR50/50100% PTHL
Portfolio after 10yr
$513766.95M
Annual income
$402,362,255,572.94/yr
Blended yield
78.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

PTHL
No analyst data
Altman Z
4.9
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTHL buys
0
EQR buys
0
No recent congressional trades found for PTHL or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTHLEQR
Forward yield710.48%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$1027533.85M$47.8K
Annual income after 10y$804,724,505,670.28$5,475.61
Total dividends collected$1009542.74M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PTHL vs EQR ($10,000, DRIP)

YearPTHL PortfolioPTHL Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$81,748$71,047.96$11,380$679.82+$70.4KPTHL
2$630,276$542,806.11$13,014$837.25+$617.3KPTHL
3$4,585,642$3,911,245.75$14,961$1,036.20+$4.57MPTHL
4$31,501,659$26,595,022.69$17,297$1,289.22+$31.48MPTHL
5$204,452,530$170,745,754.30$20,121$1,613.15+$204.43MPTHL
6$1,254,443,268$1,035,679,061.73$23,561$2,030.84+$1254.42MPTHL
7$7,281,071,470$5,938,817,172.92$27,783$2,573.54+$7281.04MPTHL
8$40,005,917,902$32,215,171,428.97$33,013$3,284.39+$40005.88MPTHL
9$208,233,035,213$165,426,703,057.98$39,547$4,223.51+$208233.00MPTHL
10$1,027,533,853,348$804,724,505,670.28$47,791$5,475.61+$1027533.81MPTHL

PTHL vs EQR: Complete Analysis 2026

PTHLStock

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.

Full PTHL Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this PTHL vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTHL vs SCHDPTHL vs JEPIPTHL vs OPTHL vs KOPTHL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.